EMMAUS MEDICAL
Emmaus Medical is a Torrance, California private pharmaceutical company developing and bringing to market new treatments for rare diseases and conditions. Emmaus Medical launched its first product, NutreStore [L-glutamine powder for an oral solution] for the treatment of Short Bowel Syndrome (SBS) in June 2008. The company is currently conducting a Phase 3 clinical trial to investigate the safety and efficacy of oral L-glutamine for the treatment of sickle cell disease. They are initially focusing our product development efforts on Sickle Cell Disease, a genetic disorder Emmaus Medical has received FDA orphan drug designation and fast track designation for its sickle cell treatment. The company was founded in 2000 and is headquartered in Torrance, California, United States.
EMMAUS MEDICAL
Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Founded:
2000-01-01
Address:
Torrance, California, United States
Country:
United States
Website Url:
http://www.emmausmedical.com
Total Employee:
11+
Status:
Active
Contact:
(877)420-6493
Email Addresses:
[email protected]
Total Funding:
99.23 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Universal Analytics Apache Amazon Google Apps For Business
Similar Organizations
Adial Pharmaceuticals
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
Agile Therapeutics
Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.
Apexigen
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
BioNTech
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Epizyme
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
Fortress Biotech
Fortress Biotech is biopharmaceutical company focused on acquiring, developing, and commercializing drugs and drug candidates.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Trevena
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-07-23 | Mynd Analytics | Mynd Analytics acquired by Emmaus Medical | N/A |
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Emmaus Medical
Agility Capital
Agility Capital investment in Debt Financing - Emmaus Medical
Official Site Inspections
http://www.emmausmedical.com Semrush global rank: 5.03 M Semrush visits lastest month: 1.66 K
- Host name: 104.43.142.33
- IP address: 104.43.142.33
- Location: Des Moines United States
- Latitude: 41.6006
- Longitude: -93.6112
- Metro Code: 679
- Timezone: America/Chicago
- Postal: 50307
More informations about "Emmaus Medical"
Mission - Emmaus Medical, Inc.
The mission of Emmaus Life Sciences is to improve the lives of people in need through the discovery, development and commercialization of innovative treatments and therapies.See details»
Investor Relations :: Emmaus Life Sciences, Inc.
Apr 14, 2025 Company. Emmaus Life Sciences, Inc. 21250 Hawthorne Blvd. Suite 800 Torrance, CA 90503 T: 310-214-0065See details»
Emmaus Medical - Crunchbase Company Profile
Emmaus Medical is a Torrance, California private pharmaceutical company developing and bringing to market new treatments for rare diseases and …See details»
Emmaus Medical, Inc. - Drug pipelines, Patents, Clinical trials
For more information, please visit www.emmausmedical.com. About Endari® (prescription grade L-glutamine oral powder) Indication - Endari® is indicated to reduce the acute complications of …See details»
Overview - Emmaus Medical, Inc.
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare …See details»
emmausmedical.com Reviews: Is this site a scam or legit?
After you read why we deemed emmausmedical.com a low-risk site, please tell us how you came across this platform in the comments.. Scam Detectors Most Trusted Websites in Online …See details»
Emmaus Medical, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Emmaus Medical, Inc. of Torrance, CA. Get the latest business insights from Dun & Bradstreet.See details»
Emmaus Medical - 2025 Company Profile, Funding, Competitors
Jul 6, 2025 Emmaus Medical - Small molecule therapeutics for the treatment of sickle cell anemia and sickle ß0-thalassemia. Acquired by Generex Biotechnology. Raised funding over …See details»
Company Information :: Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and …See details»
Emmaus Medical - The Org
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan diseases.See details»
Emmaus Medical, Inc. - CAGE.report
Primary? Code NAICS Code's Description "Buy Green"? (1) Small? (2) 1 325412 Pharmaceutical Preparation Manufacturing YesSee details»
Emmaus Medical, Inc.
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare …See details»
FAQ :: Emmaus Life Sciences, Inc. (EMMA) - ir.emmausmedical.com
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including …See details»
Emmaus Life Sciences Reports Improved Quarterly Financial Results
Dec 31, 2023 Torrance CA, November 19, 2024 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle …See details»
Emmaus Life Sciences Reports 2022 Financial Results and Provides ...
Mar 31, 2023 For more information, please visit www.emmausmedical.com. About Endari® (prescription grade L-glutamine oral powder) Endari®, Emmaus' prescription grade L …See details»
Emmaus Life Sciences Reports Annual Financial Results for 2020 …
Dec 31, 2020 Direct Sales Force - Effective January 1, 2020, Emmaus switched from the use of a contract sales organization to its own direct sales force. The company currently has 23 …See details»
News & Events :: Emmaus Life Sciences, Inc. (EMMA)
May 15, 2025 Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and …See details»
Emmaus Life Sciences Reports Q1 2022 Financial Results and …
Emmaus Life Sciences Reports Q1 2022 Financial Results and Provides Business Update. May 13, 2022See details»
Emmaus Life Sciences Announces Launch of Full-Service …
Dec 3, 2021 Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. The company currently markets U.S. Food and …See details»
Financial Information :: Emmaus Life Sciences, Inc. (EMMA)
Mar 31, 2025 Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and …See details»